| Style | Citing Format |
|---|---|
| MLA | Rovetta A, et al.. "Challenges in Assessing Statin-Associated Adverse Events." The Lancet, vol. 407, no. 10546, 2026, pp. 2373-2373. |
| APA | Rovetta A, Stovitz S D, Biscetti L, Mansournia M A (2026). Challenges in Assessing Statin-Associated Adverse Events. The Lancet, 407(10546), 2373-2373. |
| Chicago | Rovetta A, Stovitz S D, Biscetti L, Mansournia M A. "Challenges in Assessing Statin-Associated Adverse Events." The Lancet 407, no. 10546 (2026): 2373-2373. |
| Harvard | Rovetta A et al. (2026) 'Challenges in Assessing Statin-Associated Adverse Events', The Lancet, 407(10546), pp. 2373-2373. |
| Vancouver | Rovetta A, Stovitz S D, Biscetti L, Mansournia M A. Challenges in Assessing Statin-Associated Adverse Events. The Lancet. 2026;407(10546):2373-2373. |
| BibTex | @article{ author = {Rovetta A and Stovitz S D and Biscetti L and Mansournia M A}, title = {Challenges in Assessing Statin-Associated Adverse Events}, journal = {The Lancet}, volume = {407}, number = {10546}, pages = {2373-2373}, year = {2026} } |
| RIS | TY - JOUR AU - Rovetta A AU - Stovitz S D AU - Biscetti L AU - Mansournia M A TI - Challenges in Assessing Statin-Associated Adverse Events JO - The Lancet VL - 407 IS - 10546 SP - 2373 EP - 2373 PY - 2026 ER - |